1619994-69-2 - Names and Identifiers
Name | Bromosporine
|
Synonyms | CS-921 C17H20N6O4S BroMosporine Bromosporine N-[6-(3-Methanesulfonamido-4-methylphenyl)-3-methyl-[1,2,4]triazolo[4,3-b]pyridazin-8-yl]carbamate ethyl 3-Methyl-6-(4-Methyl-3-(MethylsulfonaMido)phenyl)-[1,2,4]triazolo[4,3-b]pyridazin-8-ylcarbaMate Carbamic acid, N-[3-methyl-6-[4-methyl-3-[(methylsulfonyl)amino]phenyl]-1,2,4-triazolo[4,3-b]pyridazin-8-yl]-, ethyl ester
|
CAS | 1619994-69-2
|
1619994-69-2 - Physico-chemical Properties
Molecular Formula | C17H20N6O4S
|
Molar Mass | 404.44 |
Density | 1.46±0.1 g/cm3(Predicted) |
Solubility | Soluble in DMSO (up to 25 mg/ml) |
Appearance | solid |
Color | Off-white |
pKa | 6.21±0.46(Predicted) |
Storage Condition | Sealed in dry,Store in freezer, under -20°C |
Stability | Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months. |
1619994-69-2 - Introduction
Bromosporine is an organic compound with the chemical formula C20H16BrNO2. It is a solid dissolved in organic solvents, at room temperature is gray white crystal.
Bromosporine has a variety of applications in medicine and chemical research. It is a potent protein kinase inhibitor that inhibits the activity of multiple protein kinases. Therefore, it is widely used in tumor treatment, inflammatory disease research and other related research fields.
The regular method of preparing Bromosporine is through chemical synthesis. First, benzimidazole and bromoacetate are reacted to form an intermediate, and then through a series of reaction steps, the Bromosporine product is finally obtained. The specific preparation method can refer to the relevant scientific literature or patent.
When using Bromosporine, you need to pay attention to safety matters. It is a chemical that is toxic. Appropriate personal protective equipment such as gloves, safety glasses, etc. should be worn during operation. When storing and handling Bromosporine, you should follow the correct storage and disposal methods of chemicals to avoid contact with skin, eyes, etc. In addition, when using Bromosporine, follow the relevant laboratory regulations and ensure proper ventilation conditions. If ingestion or accidental exposure occurs, seek medical advice immediately and show the safety data sheet for the compound.
Last Update:2024-04-09 21:01:54